References

1. Price RN, Nosten F, Luxemborger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi T, White NJ  1997 Artesunate / Mefloquine treatment of multi-drug resistant falciparum malaria  Trans. R. Soc. Trop. Med. Hyg. 91: 574-577

2. Nosten F  1994  Artemisinin: large community studies Trans. R. Soc. Trop. Med. Hyg. 88(Supp 1)  45-46

3. Price RN, Nosten F, Luxemborger C, ter Kuile, FO, Phaipun L, Chongsuphajaisiddhi T, White NJ  1996  Effects of artemisinin derivatives on malaria transmissibility  Lancet  347: 1654-58

4. Mehra N, Bhasin VK  1993 In vitro gametocytocidal activity of artemisinin and its derivatives on Plasmodium falciparum  Jpn. J. Med. Sci. Biol.  46:37-43

5. White NJ, Nosten F, Looareesuwan S et al  1999  Averting a malaria disaster  Lancet  353: 1965-67

6. White NJ  1998 Preventing antimalarial drug resistance through combinations  Drug Resistance Updates 1:3-9

7. White NJ, Olliaro PL  1996  Strategies for the Prevention of Antimalarial Drug Resistance: Rationale for Combination Chemotherapy for Malaria  Parasitology Today  12 (10) 399-401

8. Phillips M, Phillips-Howard PA  1996  Economic implications of resistance to anti-malarial drugs  Pharmacoeconomics 10: 225-238

9. Schapira A, Beales PF, Halloran ME  1993  Malaria: Living with Drug Resistance  Parasitology Today  9(5): 168-174

10. Rutigliano MJ 1995 Cost effectiveness analysis: a review  Neurosurgery 37: 436-444

11. Goodman CA, Coleman PG, Mill AJ   1999  Cost-effectiveness of malaria control in sub-Saharan Africa Lancet  354(9176): 378-85

12. Watkins WM, Msobo M  1993  Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half life Trans. R. Soc. Trop. Med. Hyg.  87: 75-78

13. Ronn A, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC  1996  High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania Trans. R. Soc. Trop. Med. Hyg.  90: 179-181

14. Gay F, Ciceron L, et al  1994  In vitro resistance of Plasmodium falciparum to qinghaosu derivatives in West Africa  Lancet  343:

15. Luxemborger C, Brockman A et al  1998  Two patients with falciparum malaria and poor in vivo responses to artesunate Trans. R. Soc. Trop. Med. Hyg.  92:668-669

Back to Cost Effectiveness